Anticandidal Agents
20%
off

Anticandidal Agents

By (author) 

Free delivery worldwide

Available. Dispatched from the UK in 1 business day
When will my order arrive?

Description

Anticandidal Agents provides the latest information on candida drug resistance and its remedial implications. In this compilation, users will find a comprehensive view on overcoming resistance in anticandidal drugs, along with information on novel molecules.

Candida albicans is an opportunistic pathogenic fungus responsible for life threating invasive and nosocomial infections across the globe. Candidiasis is a major cause of morbidity among immunocompromised patients. Infections caused by non-albicans candida like C. glabrata, C. parapsilosis, and C. tropicalis have also imposed a serious threat in the last few decades. Current treatment of candidiasis relies primarily on antifungal agents broadly categorized as azoles, polyenes, echinocandins, allylamines, and pyrimidines.

Lately, antifungal resistance has emerged to be an obstruction of current treatment regime. A number of reasons are described in detail. Understanding the mechanisms of resistance is crucial for developing strategies for overcoming the hindrance in current therapeutics.
show more

Product details

  • Paperback | 94 pages
  • 152 x 229 x 5.08mm | 160g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0128113111
  • 9780128113110

Table of contents

Chapter 1. Introduction

Chapter 2. Host-Pathogen Interaction

Chapter 3. Antifungals Used Against Candidiasis

Chapter 4. Drug Resistance in Candida

Chapter 5. Multidrug Resistance and Transporters

Chapter 6. Potential Anticandidal Targets

Chapter 7. Drug Development Strategies

Chapter 8. Conclusion
show more

About Awanish Kumar

Awanish Kumar is a Professor in the Bio Technology Faculty at the National Insitute of Technology Raipur, India. He has previously held posts at the National Institute of Pharma Education & Research; McGill University, Canada; and Jawaharlal Nehru University in New Dehli. His key interests in research are the development of drug targeting methods in therapeutic treatments.
show more